NCT03267459View on ClinicalTrials.gov

Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 11, 2018

Primary Completion Date

January 31, 2025

Study Completion Date

July 31, 2026

Conditions
Retinoblastoma
Interventions
DEVICE

Dynamic contrast-enhanced MRI

Dynamic contrast-enhanced perfusion sequences added to MRI examination performed at the beginning of intra arterial chemotherapy.

Trial Locations (1)

75019

RECRUITING

Fondation A De Rothschild, Paris

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK